Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-30P is a member of the U6 small nuclear RNA pseudogene family. The functional U6 small nuclear RNA (snRNA) is a highly conserved noncoding RNA involved in the spliceosome and pre-mRNA splicing in eukaryotic cells[1][3][6]. However, RNU6-30P, by definition as a pseudogene, does not produce a functional RNA molecule and does not contribute to cellular processes. Pseudogenes arise by duplication or retrotransposition of functional genes but acquire disabling mutations, rendering them nonfunctional[7]. They are typically not transcribed or, if transcribed, do not produce products with biological activity. Key context: - Functional U6 small nuclear RNA (not the pseudogene) is essential for the spliceosome, the complex responsible for pre-mRNA splicing[1][2][6]. Mutations and modifications of U6 snRNA can impact splicing efficiency but there is no evidence that the RNU6-30P pseudogene is expressed or acts in this capacity[7]. - Pseudogenes, including RNU6-30P, are generally not involved in disease, do not act as drug targets, and have no known role as biomarkers. Summary: RNU6-30P is a nonfunctional RNA pseudogene, not a tissue-expressed RNA, enzyme, receptor, or other molecular target relevant to therapeutics or diagnostics. No drugs, biomarkers, or clinical considerations exist for this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 30, pseudogene (RNU6-30P).